F&P Healthcare pushes share market higher

F&P Healthcare pushes share market higher
Dan Brunskill
Fisher & Paykel Healthcare gave the local share market a boost after Jarden analysts reiterated their ‘outperform’ rating for its ASX-listed rival ResMed.   The S&P/NZX 50 Index rose 145.14 points, or 1.1 percent, to 13,062.45. Within the index, 22 stocks rose, 21 fell and seven were unchanged. Turnover was $173.3 million.Much of the Jarden research note focused on an expectation ResMed will have strong growth in its sales of masks, a product F&P Healthcare does not sell. However, the analysts also said th...